PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The University of the West Indies, Department of Microbiology, Kingston, Jamaica.\', \'The University of the West Indies, Department of Pathology, Kingston, Jamaica.\', \'The University of the West Indies, Department of Anaesthesia and Intensive Care, Kingston, Jamaica.\', \'AstraZeneca, Department of Oncology Research, Gaithersburg, MD, United States.\', \'The University of the West Indies, Department of Surgery, Kingston, Jamaica.\', \'The University of the West Indies, Department of Basic Medical Sciences, Kingston, Jamaica.\', \'The University of the West Indies, Department of Medicine, Kingston, Jamaica.\', \'The University of the West Indies, Department of Microbiology, Kingston, Jamaica; Global Virus Network, Baltimore, MD, United States. Electronic address: joshua.anzinger@uwimona.edu.jm.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00145-410.1016/j.ijid.2021.02.059
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33610776
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of commercial SARS-CoV-2 antibody assays, Jamaica.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all